Annual Total Long Term Liabilities
$842.40 K
+$66.80 K+8.61%
30 June 2024
Summary:
Renovaro Biosciences annual total long term liabilities is currently $842.40 thousand, with the most recent change of +$66.80 thousand (+8.61%) on 30 June 2024. During the last 3 years, it has fallen by -$12.21 million (-93.55%). RENB annual total long term liabilities is now -96.32% below its all-time high of $22.89 million, reached on 01 June 2018.RENB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$710.30 K
-$132.10 K-15.68%
30 September 2024
Summary:
Renovaro Biosciences quarterly total long term liabilities is currently $710.30 thousand, with the most recent change of -$132.10 thousand (-15.68%) on 30 September 2024. Over the past year, it has increased by +$46.10 thousand (+6.94%). RENB quarterly long term liabilities is now -97.02% below its all-time high of $23.82 million, reached on 01 March 2019.RENB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.6% | +6.9% |
| 3 y3 years | -93.5% | -93.7% |
| 5 y5 years | -85.1% | -88.1% |
RENB Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -93.5% | +8.6% | -96.9% | +6.9% |
| 5 y | 5 years | -93.5% | +8.6% | -96.9% | +6.9% |
| alltime | all time | -96.3% | -97.0% |
Renovaro Biosciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $710.30 K(-15.7%) |
| June 2024 | $842.40 K(+8.6%) | $842.40 K(-96.3%) |
| Mar 2024 | - | $22.81 M(+3334.2%) |
| Dec 2023 | - | $664.20 K(-7.9%) |
| Sept 2023 | - | $720.80 K(-7.1%) |
| June 2023 | $775.60 K(-86.1%) | - |
| June 2023 | - | $775.60 K(-6.5%) |
| Mar 2023 | - | $829.20 K(-60.2%) |
| Dec 2022 | - | $2.08 M(-62.7%) |
| Sept 2022 | - | $5.59 M(+0.4%) |
| June 2022 | $5.56 M(-57.4%) | $5.56 M(-51.0%) |
| Mar 2022 | - | $11.35 M(+0.3%) |
| Dec 2021 | - | $11.31 M(-28.7%) |
| Sept 2021 | - | $15.88 M(+21.6%) |
| June 2021 | $13.06 M(+24.4%) | $13.06 M(+31.0%) |
| Mar 2021 | - | $9.97 M(+6.2%) |
| Dec 2020 | - | $9.39 M(-6.8%) |
| Sept 2020 | - | $10.07 M(-4.0%) |
| June 2020 | $10.49 M(+85.2%) | $10.49 M(+12.7%) |
| Mar 2020 | - | $9.31 M(+55.6%) |
| Dec 2019 | - | $5.99 M(-16.1%) |
| Sept 2019 | - | $7.14 M(+25.9%) |
| June 2019 | $5.67 M(-75.2%) | $5.67 M(-76.2%) |
| Mar 2019 | - | $23.82 M(+0.9%) |
| Dec 2018 | - | $23.60 M(+10.2%) |
| Sept 2018 | - | $21.42 M(-6.4%) |
| June 2018 | $22.89 M | $22.89 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | - | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | - | $309.60 K(-6.9%) |
| Sept 2016 | - | $332.60 K(>+9900.0%) |
| June 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | - | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | $0.00(0.0%) | - |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | - | $0.00 |
| Mar 2011 | $0.00 | - |
FAQ
- What is Renovaro Biosciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Renovaro Biosciences?
- What is Renovaro Biosciences annual total long term liabilities year-on-year change?
- What is Renovaro Biosciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly long term liabilities year-on-year change?
What is Renovaro Biosciences annual total long term liabilities?
The current annual total long term liabilities of RENB is $842.40 K
What is the all time high annual total long term liabilities for Renovaro Biosciences?
Renovaro Biosciences all-time high annual total long term liabilities is $22.89 M
What is Renovaro Biosciences annual total long term liabilities year-on-year change?
Over the past year, RENB annual total long term liabilities has changed by +$66.80 K (+8.61%)
What is Renovaro Biosciences quarterly total long term liabilities?
The current quarterly long term liabilities of RENB is $710.30 K
What is the all time high quarterly long term liabilities for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly total long term liabilities is $23.82 M
What is Renovaro Biosciences quarterly long term liabilities year-on-year change?
Over the past year, RENB quarterly total long term liabilities has changed by +$46.10 K (+6.94%)